Title : Osimertinib 160 mg daily for advanced non-small cell lung cancer with leptomeningeal metastasis: A case report.

Pub. Date : 2019 Oct

PMID : 31642175






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In preclinical and clinical studies, the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor osimertinib has demonstrated activity in the central nervous system (CNS), and studies are ongoing. Tyrosine epidermal growth factor receptor Homo sapiens
2 In preclinical and clinical studies, the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor osimertinib has demonstrated activity in the central nervous system (CNS), and studies are ongoing. Tyrosine epidermal growth factor receptor Homo sapiens